Balleza Alejandri et al. Empagliflozin and Dapagliflozin Improve Endothelial Function in Mexican Patients with Type 2 Diabetes Mellitus: A Double-Blind Clinical Trial (vol 11,182,2024)

被引：0
|
作者：
Alejandri, Luis Ricardo Balleza [1 ]
Paez, Fernando Grover [1 ,2 ]
Campos, Erick Gonzalez [1 ]
Becerra, Carlos G. Ramos [1 ,2 ]
Munoz, Ernesto German Cardona [1 ,2 ]
Gonzalez, Sara Pascoe [1 ,2 ]
Zavala, Maria Guadalupe Ramos [1 ,2 ]
Roa, Africa Samantha Reynoso [1 ,2 ]
Rico, Daniel Osmar Suarez [1 ]
Ramirez, Alberto Beltran [1 ]
Galindo, Jesus Jonathan Garcia [1 ]
Mueller, David Cardona [1 ,2 ]
Ruiz, Claudia Yanette Galan [1 ,2 ]
机构：
[1] Univ Guadalajara, Univ Hlth Sci Ctr, Dept Physiol, Guadalajara 44340, Mexico
[2] Univ Guadalajara, Univ Hlth Sci Ctr, Expt & Clin Therapeut Inst, Dept Physiol,Arterial Stiffness Lab, Guadalajara 44340, Mexico
来源：
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE | 2024年 / 11卷 / 10期
关键词：
D O I：
10.3390/jcdd11100314
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Empagliflozin and Dapagliflozin Improve Endothelial Function in Mexican Patients with Type 2 Diabetes Mellitus: A Double-Blind Clinical Trial
    Alejandri, Luis Ricardo Balleza
    Paez, Fernando Grover
    Campos, Erick Gonzalez
    Becerra, Carlos G. Ramos
    Munoz, Ernesto German Cardona
    Gonzalez, Sara Pascoe
    Zavala, Maria Guadalupe Ramos
    Roa, Africa Samantha Reynoso
    Rico, Daniel Osmar Suarez
    Ramirez, Alberto Beltran
    Galindo, Jesus Jonathan Garcia
    Mueller, David Cardona
    Ruiz, Claudia Yanette Galan
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2024, 11 (06)
  • [2] THE EFFECT OF DAPAGLIFLOZIN ON 24-HOUR BLOOD PRESSURE IN PATIENTS WITH TYPE-2 DIABETES MELLITUS: A DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL
    Papadopoulou, Eirini
    Loutradis, Charalampos
    Tzatzagou, Glyceria
    Kotsa, Kalliopi
    Zografou, Loanna
    Minopoulou, Loanna
    Theodorakopoulou, Marieta
    Tsapas, Apostolos
    Karagiannis, Asterios
    Sarafidis, Pantelis
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1349 - 1349
  • [3] Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo-controlled double-blind randomized effect of empagliflozin on endothelial function in cardiovascular high risk diabetes mellitus: Multi-center placebo-controlled double-blind randomized trial
    Tanaka, Atsushi
    Shimabukuro, Michio
    Machii, Noritaka
    Teragawa, Hiroki
    Okada, Yosuke
    Shima, Kosuke R.
    Takamura, Toshinari
    Taguchi, Isao
    Hisauchi, Itaru
    Toyoda, Shigeru
    Matsuzawa, Yasushi
    Tomiyama, Hirofumi
    Yamaoka-Tojo, Minako
    Ueda, Shinichiro
    Higashi, Yukihito
    Node, Koichi
    JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (06) : 1551 - 1563
  • [4] Comparison of paroxetine and agomelatine in depressed type 2 diabetes mellitus patients: a double-blind, randomized, clinical trial
    Kang, Ruiying
    He, Yan
    Yan, Yuxiang
    Li, Zhiwu
    Wu, Yeqing
    Guo, Xiaojuan
    Liang, Zhigang
    Jiang, Jun
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 : 1307 - 1311
  • [5] Clinical Trial for Effectiveness of Dapagliflozin on Vascular Endothelial Function and Glycemic Control in Type 2 Diabetes Mellitus Patients: DEFENCE Study
    Shigiyama, Fumika
    Kumashiro, Naoki
    Miyagi, Masahiko
    Ikehara, Kayoko
    Kanda, Eiichiro
    Uchino, Hiroshi
    Hirose, Takahisa
    DIABETES, 2017, 66 : LB3 - LB3
  • [6] THE EFFECT OF DAPAGLIFLOZIN ON AMBULATORY AORTIC BLOOD PRESSURE AND ARTERIAL STIFFNESS PARAMETERS IN PATIENTS WITH TYPE-2 DIABETES MELLITUS: A DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL
    Papadopoulou, Eirini
    Loutradis, Charalampos
    Kotsa, Kalliopi
    Karras, Spiros
    Sambanis, Christos
    Tzatzagou, Glyceria
    Karakozoglou, Anastasios
    Didangelos, Triantafillos
    Theodorakopoulou, Marieta
    Minopoulou, Loanna
    Tsapas, Apostolos
    Karagiannis, Asterios
    Sarafidis, Pantelis
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 41 - 41
  • [7] THE EFFECT OF DAPAGLIFLOZIN ON 24-HOUR BLOOD PRESSURE AND ARTERIAL STIFFNESS IN PATIENTS WITH TYPE-2 DIABETES MELLITUS: A DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL
    Papadopoulou, Eirini
    Loutradis, Charalampos
    Tzatzagou, Glyceria
    Kotsa, Kalliopi
    Zografou, Ioanna
    Minopoulou, Ioanna
    Theodorakopoulou, Marieta
    Tsapas, Apostolos
    Karagiannis, Asterios
    Sarafidis, Pantelis
    JOURNAL OF HYPERTENSION, 2021, 39 : E25 - E25
  • [8] A randomized double-blind phase Ib clinical trial of SY-009 in patients with type 2 diabetes mellitus
    Huang, Lei
    Cao, Bei
    Geng, Yan
    Zhou, Xiaoli
    Yang, Yuanxun
    Ma, Tingting
    Lin, Hui
    Huang, Zhijiang
    Zhuo, Lang
    Li, Juan
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 192
  • [9] Ficus carica Leaves Decoction on Glycemic Factors of Patients With Type 2 Diabetes Mellitus: A Double-Blind Clinical Trial
    Mazhin, Sadegh Ahmadi
    Zaker, Marziyeh Asadi
    Shahbazian, Hajie Bibi
    Azemi, Mohammad Ebrahim
    Madanchi, Nima
    JUNDISHAPUR JOURNAL OF NATURAL PHARMACEUTICAL PRODUCTS, 2016, 11 (01)
  • [10] Effect of Empagliflozin on Endothelial Function in Patients With Type 2 Diabetes and Cardiovascular Disease: Results from the Multicenter, Randomized, Placebo-Controlled, Double-Blind EMBLEM Trial
    Tanaka, Atsushi
    Shimabukuro, Michio
    Machii, Noritaka
    Teragawa, Hiroki
    Okada, Yosuke
    Shima, Kosuke R.
    Takamura, Toshinari
    Taguchi, Isao
    Hisauchi, Itaru
    Toyoda, Shigeru
    Matsuzawa, Yasushi
    Tomiyama, Hirofumi
    Yamaoka-Tojo, Minako
    Yoshida, Hisako
    Sato, Yasunori
    Ikehara, Yumi
    Ueda, Shinichiro
    Higashi, Yukihito
    Node, Koichi
    DIABETES CARE, 2019, 42 (10) : E159 - E161
12345